DSCP1 inhibitors are a class of chemical compounds designed to inhibit the activity of DSCP1, a protein involved in cellular signaling and regulatory mechanisms. DSCP1, also known as Desmosome-Associated Protein 1, is believed to play a role in the structural and functional integrity of desmosomes, which are specialized intercellular junctions responsible for maintaining cell adhesion in tissues subjected to mechanical stress. While the exact function of DSCP1 is still being studied, it is thought to contribute to the stability of the desmosomal complex by interacting with other key proteins, thereby supporting cellular cohesion and tissue organization. By inhibiting DSCP1, these compounds disrupt its involvement in maintaining proper cell adhesion dynamics, potentially affecting desmosome assembly and stability.
Structurally, DSCP1 inhibitors are typically designed to target specific domains of the DSCP1 protein that are critical for its function within the desmosomal network. These inhibitors may prevent the interaction of DSCP1 with other desmosomal proteins or interfere with its ability to bind to cellular components necessary for desmosome formation and maintenance. Inhibition of DSCP1 offers a valuable tool for exploring the protein's role in cell adhesion and the broader implications for tissue architecture and mechanical resilience. Studying DSCP1 inhibitors helps researchers to better understand how desmosomal complexes are regulated and maintained, and how disruptions in these processes might lead to alterations in tissue integrity. The development of DSCP1 inhibitors contributes to a broader comprehension of intercellular junctions and their importance in cellular communication and structural stability within multicellular organisms.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
Inhibits PI3K, potentially altering signaling cascades involving DSCP1. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
PI3K inhibitor, could adjust cellular processes regulated by DSCP1. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
Inhibits p38 MAPK, may modulate DSCP1 activity through stress response pathways. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
Inhibits MEK1/2, could affect DSCP1 by altering the MAPK/ERK pathway. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Inhibits mTOR, may regulate DSCP1 function via protein synthesis control. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
Inhibits MEK, could control DSCP1 activity through the MAPK/ERK pathway. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
Inhibits JNK, may influence DSCP1 through stress and inflammatory response pathways. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Inhibits ROCK, could impact DSCP1 by modulating cytoskeletal dynamics. | ||||||
Triciribine | 35943-35-2 | sc-200661 sc-200661A | 1 mg 5 mg | $104.00 $141.00 | 14 | |
Inhibits AKT, could adjust DSCP1 activity related to cell survival and growth signals. | ||||||
ZM-447439 | 331771-20-1 | sc-200696 sc-200696A | 1 mg 10 mg | $153.00 $356.00 | 15 | |
Inhibits Aurora kinase, could affect DSCP1 function involved in cell cycle control. | ||||||